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Abstract
U.S. government subsidies under the HITECH Act of
2009 have boosted hospitals’ IT investments, which are
expected to improve the quality of care as well as the
effectiveness of healthcare management. Given the rush
to adopt health information technology (HIT)
throughout the continuum of care across healthcare
providers, this study tries to identify the spillover effects
of HIT adoption on quality of care. Using 1,965 U.S.
hospital data in 232 health referral regions (HRRs), we
examine how a hospital’s and its neighboring hospitals’
HIT adoptions interact with each other and how they
impact readmission rates. We find that a hospital’s
readmission rate is reduced by both its own and
neighbors’ HIT adoption. Such effects become greater
along with the focal hospital’s own adoption. We further
investigate how spillover effects vary with HRRs’
different market structures and hospitals’ meaningfuluse status. Our findings offer theoretical and
managerial insights for both healthcare researchers
and practitioners.

1. Introduction
Health information technology (HIT) has been
expected to help healthcare providers better manage the
timeliness and accuracy of patient care by supporting
effective clinical decisions and information sharing
among patients and their caregivers. Thanks to the
Health Information Technology for Economic and
Clinical Health (HITECH) Act of 2009, U.S. healthcare
providers have been given financial incentives linked to
HIT adoption. More than $35 billion in incentives has
promoted HIT implementation, resulting in 96% of
hospitals having a certified electronic health records
program in 2017—a nine-fold increase since 2008 [22].

1

A clinical decision support system (CDSS) uses knowledge bases
for providing clinical information at the point of care to drive
evidence-based treatment (e.g., clinical guidelines and reminders,
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During the last decade, this dramatically increased
HIT adoption has promoted healthcare researchers
justify the government initiatives to drive large private
and public investments. However, most of the prior
studies have focused on the hospital- or physician-level
effects of HIT adoption on healthcare quality and costs
[1, 2, 6].
However, unlike other industries, the healthcare
sector often shares patient information as patients move
across healthcare providers within a hospital referral
region (HRR). Thus, a hospital’s HIT adoption does not
only affect the adopter itself but also its neighboring
hospitals. For instance, clinical and patient information
from a clinical decision support system (CDSS) 1 is
utilized by physicians in writing referral letters, which
inform the medical decisions of referred hospitals in an
HRR. Primary care physicians’ referrals to special
services are often accompanied by information sharing
through electronic data interchange (EDI), which
expedites communication and collaboration among
healthcare providers [17]. Therefore, the HIT adoptions
of hospitals in an HRR seem to have spillover effects.
In addition, the patterns of such referrals vary with
an HRR’s market structure. If a single tertiary hospital
dominates a local healthcare market, all primary and
secondary care hospitals would not have any choice,
whereas they would have multiple options otherwise.
Thus, the spillover effect of HIT adoption on quality of
care in HRRs having various market structures is an
important empirical question.
Although HIT adoption can result in the spillover
effects in terms of better healthcare outcomes, some
studies demonstrated that most of the benefits from HIT
adoption are not caused by the simple implementation.
The assimilation gap between the implementation and
the actual usage of HIT [12] would explain the effects
of HITs. Thus, we further consider the meaningful use
of adopted HIT in our empirical models.

drug allergy and drug-drug interaction alerts, and drug dosing support).
It can integrate clinical workflows by supporting various managerial
as well as medical decisions throughout the continuum of care.
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With regard to the above discussions, our primary
research questions are: (1) How does a hospital’s HIT
adoption affect its quality of care? (2) Do the spillover
effects of HIT adoption exist among hospitals in an
HRR? (3) How do the spillover effects vary with
different market structures? (4) How is the meaningful
use of HITs related to the effects on healthcare quality?
In order to answer the questions, the large-scale
hospital panel datasets were obtained from multiple
sources, including the Healthcare Information and
Management Systems Society (HIMSS) Analytics
database and the Centers for Medicare and Medicaid
Services (CMS) website 2 . Our sample includes
healthcare data involving 1,965 hospitals across 232
HRRs from 2010 to 2015, such as adopted HITs and
detailed healthcare quality.
Our findings provide theoretical and practical
implications by identifying the interdependence of HIT
adoption among hospitals in an HRR. The contribution
of the study lies in providing policy insights on effective
healthcare policies across complex healthcare market
structures.

2. Research background
The impact of HIT adoption has recently drawn
attention from the community of Information Systems
[1]. Several efforts have been devoted to examining its
impacts on diverse dimensions, including productivity
[7, 11, 13, 16, 20, 24], medical errors [2, 8, 15, 18],
insurance premiums [19], and healthcare quality [4, 6,
14, 23]. For example, Menon et al. [20] show that two
healthcare information systems—clinical information
systems and administrative information systems—have
different impacts on patient days and medical labor
productivity. Based on the results, they argue that
aggregating HIT investment may not lead to a correct
conclusion due to these different effects. Aron et al. [2]
provide empirical evidence that automating the core
error prevention functions between hospitals reduced
their interpretative and procedural medical errors.
Menon and Kohli [19] analyze hospital panel data in
Washington State and show that past HIT expenditures,
measured by depreciation expenses, are negatively
associated with malpractice insurance premiums and are
positively associated with healthcare quality. Bhargava
and Mishra [7] focus on physician productivity after
adopting electronic health records systems. They found
that such an adoption could bring about immediate
drops in physician productivity; however, these

2

The Centers for Medicare & Medicaid Services (CMS) is a federal
agency as part of the U.S. Department of Health and Human Services.
CMS serves Medicare and Medicaid beneficiaries and also oversees

productivity drops can be recouped in the long run if the
systems are a good fit with physicians’ task
requirements.
A few recent studies [3, 5, 21] have focused on the
inter-organizational effects of HIT adoption, as well.
Most notably, Atasoy et al. [3] find that adopting
electronic health records reduces the cost of neighboring
hospitals by creating significant regional spillover
effects. Ayabakan et al. [5] show that medical test
duplication can be reduced with inter-organizational
information-sharing technologies.
While prior literature has studied the effects of HIT
from diverse perspectives, no study has considered the
spillover effects of HIT on quality of care in HRRs
having different market competitions. Thus, we aim to
address these gaps in the literature by empirically
examining how the interaction between the HIT
adoptions of a focal hospital and its neighboring
hospitals in an HRR influence quality of care. We focus
not only on the main effect of HIT adoption but also on
its spillover effects within the HRR. We also compare
the spillover effects across HRRs with different market
concentrations and discuss the role of meaningful use in
generating the effects.
Furthermore, we examine the technology
interdependence between two HIT applications,
particularly the role of EDI in generating the spillover
effects of an adopted CDSS. Considering the spillover
effects of HIT adoption in an HRR, EDI is one of the
most important factors to facilitate the network effects
of other HITs, while CDSS is a HIT application related
to avoidance of errors and right clinical decisions
resulting in enhanced health outcomes. Thus, to answer
our research questions, we focus on investigating the
spillover effects of a hospital’s EDI and CDSS adoption
on its readmission rate, which is a widely accepted
measure of healthcare quality.
Our study provides evidence that the adoptions of
both EDI and CDSS are positively associated with a
subsequent reduction in readmission rates for heart
failure across hospitals in the U.S. We also find that the
average adoption rate of a hospital’s neighbors is
significantly associated with a subsequent reduction in
the hospital’s readmission rate. The effect is greater
when both a hospital and its neighbors in an HRR have
adopted the same technology. Lastly, the meaningful
use of HITs, which is captured by the Stage 2 certificate,
plays a role in explaining the HIT effects.
The rest of the paper is organized as follows. We
first describe our data and empirical model; then, we
show the main analysis results. Subsequently, we
many federal healthcare programs, including those that involve HIT
such as the meaningful use incentive program for electronic health
records (EHR).
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conduct an analysis across subsamples with different
market concentrations. Next, we examine whether EDI
adoption supports the spillover effects of CDSS
adoption in an HRR. We also conduct an HRR-level
analysis to demonstrate the relationship between the
average adoption rate of EDI and CDSS, as well as the
hospital readmission rate of HRRs. Lastly, we examine
how the meaningful use of HITs is related to the effects.
We conclude our paper with theoretical contributions
and future research directions.
3.

Empirical analysis

3.1. Data description
We obtained data from multiple sources. Hospitals’
IT infrastructure, HIT adoption, operating expenses and
other organizational characteristics were collected from
the HIMSS Analytics database. Readmission rates and
meaningful-use status were collected from the CMS
website. We matched the observations of the same
hospital from different sources based on Medicare
provider codes, hospital names, addresses and zip codes.
Our interests reside in Medicare hospitals whose
information has been publicly announced. Further, to
examine possible spillover effects within an HRR, we
chose HRRs that have at least three Medicare hospitals.
The final longitudinal sample includes 232 HRRs and
1,965 hospitals that have reported their annual status
from 2010 to 2015.
As noted earlier, in order to identify the spillover
effects of HIT on quality of care, this study focuses on
examining the effects of EDI and CDSS on subsequent
readmission rates for heart failure patients.
A hospital readmission is defined as “an unplanned
admission to an acute care hospital within 30 days of

discharge from the same or another acute care hospital”
[10]. Readmission rates were collected from CMS as a
three-year rolling average at the hospital level for heart
failure. Readmission indicates a poor quality of
healthcare service during the initial hospitalization,
because a discharged patient’s health has worsened and
financial costs increase. Since the U.S. government
financially penalizes hospitals whose readmission rates
are above a projected rate, hospitals have striven to
lower their readmission rates. While a readmission rate
has been accepted as a core quality measure, heart
failure has been the leading diagnosis of hospital
readmission, with a median risk-standardized
readmission rate of 23%, from 2009 to 2012 [9].
Table 1 provides the definition and summary
statistics of the main variables used in our analysis.
Figure 1 illustrates the HRRs across states, which are
used in our analysis. A larger and darker circle
represents that more hospitals exist in the HRR.

Figure 1. Hospitals in HRRs

Table 1. Definition of key variables and descriptive statistics
Variables

Definition
N
Mean
SD
Min
Max
Readmission rate of heart failure within 30 days
rhfscore
9,541
0.228
0.020
0.158
0.321
following a discharge
One year lagged adoption status of electronic
EDI
9,541
0.930
0.255
0
1
data interchange (1=implemented, 0=otherwise)
One year lagged adoption ratio of the clinical
CDSS
9,541
0.691
0.342
0
1
decision support system
ln(nofcda)
Number of computerized document applications
9,541
1.351
0.124
0
1.386
ln(nofbeds) Number of beds
9,541
5.111
0.958
2.565
7.533
ln(opexp)
Operating expense (USD)
9,541
18.690
1.093
14.927
22.975
ln(nofhrr)
Number of hospitals in the referral regions
9,541
2.477
0.627
1.386
3.807
HHI
Herfindahl-Hirschman Index of referral regions
9,541
0.218
0.148
0.032
0.859
Note: A clinical decision support system includes drug content and interactions, clinical guidelines and pathways for physicians,
as well as clinical guidelines and pathways for nurses; computerized document applications include computerized practitioner order
entries, clinical data repositories, electronic medical records, and electronic medication administration records.
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3.2. Empirical approach
We employ a fixed effects model that controls for
time-invariant hospital-level covariates. We examine
how a hospital’s (and its neighboring hospitals’) HIT
adoptions affect the hospital’s readmission rate (Eq. 1).
We also consider the network effect of HIT adoption by
incorporating the interaction term between the HIT
adoption of the focal hospital and the adoption rate of its
neighbors in an HRR into the main effect model (Eq. 2).
Our model specifications are:
𝑟ℎ𝑓𝑖,𝑡 = 𝛽0 + 𝛽1 𝐻𝐼𝑇𝑖,𝑡−1 + 𝛽2 𝐻𝐼𝑇𝑟−𝑖,𝑡−1 + 𝛾𝑋𝑖,𝑡
+𝜇𝑖 + 𝜀𝑖,𝑡
(Eq. 1)
𝑟ℎ𝑓𝑖,𝑡 = 𝛽0 + 𝛽1 𝐻𝐼𝑇𝑖,𝑡−1 + 𝛽2 𝐻𝐼𝑇𝑟−𝑖,𝑡−1
+𝛽3 𝐻𝐼𝑇𝑖,𝑡−1 × 𝐻𝐼𝑇𝑟−𝑖,𝑡−1 + 𝛾𝑋𝑖,𝑡 + 𝜇𝑖 + 𝜀𝑖,𝑡 (Eq. 2)

where 𝑟ℎ𝑓𝑖,𝑡 is the readmission rate of the heart failure
cases of hospital i at time t, 𝐻𝐼𝑇𝑖,𝑡−1 is the adoption state
of the HIT (EDI or CDSS) of hospital i at time t-1,
𝐻𝐼𝑇𝑟−𝑖,𝑡−1 is the average adoption rate of the other
hospitals in the same HRR r, except for the focal
hospital i at time t-1, 𝑋𝑖,𝑡 is a vector of the control
variables, 𝜇𝑖 is the hospital-specific fixed effects, and
𝜀𝑖,𝑡 is the disturbance term.
Our control variables are time-varying hospital-level
covariates, including the number of computerized
document applications, number of beds, operating
expenses, and an HRR’s market concentration. The
number of computerized healthcare systems are
included to control for effects due to the hospitals’ IT
infrastructure. The number of beds and the operating
expenses are included to control for the effect of
organizational size. The number of hospitals and the
Herfindahl-Hirschman Index (HHI) are included to
control HRR’s market structure. Lastly, our fixed effects
term controls for effects due to all time-invariant
hospital-specific factors.

3.3. Results
Table 2 illustrates our results. Models (1) and (3)
indicate that the coefficients of 𝐻𝐼𝑇𝑖,𝑡−1 are negative
and significant for both EDI and CDSS (-0.006 and 0.005 at p-value <0.01, respectively), demonstrating
that the adoption status of those HITs is negatively
associated with the subsequent readmission rates of
heart failure patients. This result provides evidence of
the positive effects of EDI and CDSS adoption on
quality of care. 𝐻𝐼𝑇𝑟−𝑖,𝑡−1 also has a negative and
significant coefficient for both EDI and CDSS (-0.058

and -0.065 at p-value <0.01, respectively), implying that
the average adoption rate of a hospital’s neighboring
hospitals in an HRR is negatively associated with the
subsequent readmission rate of the focal hospital. The
results demonstrate the spillover effects of HITs within
an HRR.
In Models (2) and (4), we investigate the interaction
effect between the adoption status of the focal hospital
and the average adoption rate of the other hospitals. The
coefficients of the interaction term of 𝐻𝐼𝑇𝑖,𝑡−1 and
𝐻𝐼𝑇𝑟−𝑖,𝑡−1 are negative and significant for both EDI and
CDSS (-0.016 at p-value <0.01 and -0.012 at p-value
<0.05, respectively). These suggest that the spillover
effects of HIT are stronger when both the focal hospital
and its neighbors have adopted the same type of HIT.
Among the control variables, the number of
computerized document applications (nofcdai,t), the
number of beds (nofbedi,t), the operating expense
(opexpi,t), and the Herfindahl-Hirschman Index (HHIi,t)
are negatively associated with the readmission rate. The
number of hospitals in the referral region (nofhrri,t) is
omitted from the analysis due to high multi-collinearity
with other covariates (Mean VIF=14.22 in Model (6)).

4. Additional analysis
4.1. Subsample analysis
With respect to our discussion in the introduction, a
hospital’s choice for referrals requiring communication
and information sharing between practitioners should be
related to an HRR’s market structure. We employ the
Herfindahl-Hirschman Index (HHI), which is a
commonly accepted measure for market concentration
in considering the spillover effects across HRRs having
diverse market structures. According to the U.S.
Department of Justice and the Federal Trade
Commission, an index below 0.15 indicates that the
market is unconcentrated, and an index between 0.15
and 0.25 indicates that the market is moderately
concentrated. An index above 0.25 indicates that the
market is highly concentrated. We employ this cutoff to
classify the HRRs each year. Our dataset includes 855,
507, and 603 hospitals in the low, moderate, and high
market concentration groups, respectively.
We replicate our panel analysis for these three
subsamples. Tables 3, 4, and 5 show the results from
HHRs with an HHI of less than 0.15 (Panel A), between
0.15 and 0.25 (Panel B), and more than 0.25 (Panel C),
respectively.
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Table 2. Estimation results
Variables
𝐸𝐷𝐼𝑖,𝑡−1
𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(1)
-0.006***
(0.001)
-0.058***
(0.002)

𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(2)
0.007
(0.005)
-0.044***
(0.006)
-0.016***
(0.006)

𝐶𝐷𝑆𝑆𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1

(3)

(4)

-0.005***
(0.002)
-0.065***
(0.003)

0.002
(0.004)
-0.056***
(0.004)
-0.012**
(0.005)

𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(5)
0.002
(0.005)
-0.024***
(0.006)
-0.005
(0.006)
0.006*
(0.004)
-0.039***
(0.005)
-0.010*
(0.005)
-0.005*
(0.003)

𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 × 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1
-0.022***
-0.022***
-0.020***
(0.002)
(0.002)
(0.002)
-0.003
-0.003
-0.004**
ln(𝑛𝑜𝑓𝑏𝑒𝑑𝑖,𝑡 )
(0.002)
(0.002)
(0.002)
-0.004***
-0.004***
-0.004***
ln(𝑜𝑝𝑒𝑥𝑝𝑖,𝑡 )
(0.001)
(0.001)
(0.001)
-0.042***
-0.042***
-0.036***
𝐻𝐻𝐼𝑖,𝑡
(0.004)
(0.004)
(0.004)
0.408***
0.397***
0.414***
Constant
(0.021)
(0.022)
(0.021)
Fixed-effects
Yes
Yes
Yes
R2
0.244
0.245
0.275
Observations
9,541
9,541
9,541
Number of hospitals
1,965
1,965
1,965
Note: Robust standard errors are in parentheses; ***p<0.01, **p<0.05, *p<0.1.
ln(𝑛𝑜𝑓𝑐𝑑𝑎𝑖,𝑡 )

-0.020***
(0.002)
-0.004**
(0.002)
-0.004***
(0.001)
-0.036***
(0.004)
0.410***
(0.021)
Yes
0.276
9,541
1,965

-0.018***
(0.002)
-0.004*
(0.002)
-0.003***
(0.001)
-0.032***
(0.004)
0.391***
(0.020)
Yes
0.307
9,541
1,965

(6)
0.001
(0.005)
-0.028***
(0.006)
0.000
(0.008)
0.003
(0.003)
-0.030***
(0.006)
-0.011**
(0.005)
-0.010*
(0.005)
-0.018***
(0.002)
-0.004*
(0.002)
-0.003***
(0.001)
-0.032***
(0.004)
0.389***
(0.020)
Yes
0.307
9,541
1,965

Table 3. Estimation results for HRRs with an HHI below 0.15 (Panel A)
Variables
𝐸𝐷𝐼𝑖,𝑡−1
𝐸𝐷𝐼𝑟−𝑖,𝑡−1
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(1)
-0.007***
(0.002)
-0.093***
(0.004)

(2)
0.009
(0.011)
-0.076***
(0.013)
-0.019
(0.013)

(3)

(4)

-0.005**
(0.002)
-0.099***
(0.005)

0.006
(0.006)
-0.086***
(0.008)
-0.018**
(0.009)

(5)
0.004
(0.012)
-0.017
(0.014)
-0.012
(0.014)
0.008
(0.006)
-0.062***
(0.010)
-0.025**
(0.010)
0.005
(0.006)

(6)
-0.009
(0.014)
-0.030*
(0.016)
0.022
(0.020)
0.004
(0.007)
-0.050***
(0.011)
-0.014
(0.010)

-0.025**
(0.012)
0.365***
0.350***
0.341***
0.334***
0.327***
0.332***
Constants
(0.035)
(0.038)
(0.033)
(0.033)
(0.035)
(0.036)
Controls
Yes
Yes
Yes
Yes
Yes
Yes
Fixed-effects
Yes
Yes
Yes
Yes
Yes
Yes
R2
0.303
0.304
0.357
0.358
0.364
0.365
Observations
4,168
4,168
4,168
4,168
4,168
4,168
Number of hospitals
855
855
855
855
855
855
Note: Robust standard errors are in parentheses. *** p<0.01, ** p<0.05, * p<0.1. The results of the control variables are not shown
for expositional brevity.
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 × 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1
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Table 4. Estimation results for HRRs with an HHI between 0.15 and 0.25 (Panel B)
Variables

(1)
-0.004*
(0.002)
-0.061***
(0.004)

𝐸𝐷𝐼𝑖,𝑡−1
𝐸𝐷𝐼𝑟−𝑖,𝑡−1
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(2)
0.016
(0.010)
-0.040***
(0.011)
-0.024**
(0.011)

𝐶𝐷𝑆𝑆𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1

(3)

(4)

-0.005*
(0.003)
-0.066***
(0.005)

-0.006
(0.008)
-0.068***
(0.010)
0.002
(0.012)

𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(5)
0.015
(0.011)
-0.017
(0.012)
-0.015
(0.013)
0.003
(0.009)
-0.051***
(0.011)
0.005
(0.013)
-0.013**
(0.006)

𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 × 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1
Constants
Controls
Fixed-effects
R2
Observations
Number of hospitals

0.427***
(0.046)
Yes
Yes
0.221
2,481
507

0.411***
(0.047)
Yes
Yes
0.223
2,481
507

0.403***
(0.045)
Yes
Yes
0.250
2,481
507

0.403***
(0.045)
Yes
Yes
0.250
2,481
507

0.379***
(0.044)
Yes
Yes
0.291
2,481
507

(6)
0.019
(0.012)
-0.015
(0.013)
-0.030*
(0.017)
-0.003
(0.008)
-0.052***
(0.013)
-0.002
(0.013)

0.007
(0.011)
0.381***
(0.044)
Yes
Yes
0.289
2,481
507

Note: Robust standard errors are in parentheses. ***p<0.01, **p<0.05, *p<0.1. The results of the control variables are
not shown for expositional brevity.
Table 5. Estimation results for HRRs with an HHI above 0.25 (Panel C)
Variables
𝐸𝐷𝐼𝑖,𝑡−1
𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(1)
-0.005**
(0.002)
-0.040***
(0.002)

𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(2)
-0.000
(0.006)
-0.035***
(0.007)
-0.005
(0.008)

𝐶𝐷𝑆𝑆𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1

(3)

(4)

-0.004*
(0.002)
-0.044***
(0.003)

-0.000
(0.004)
-0.040***
(0.005)
-0.006
(0.007)

𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(5)
-0.004
(0.006)
-0.025***
(0.007)
0.007
(0.008)
0.007
(0.005)
-0.030***
(0.006)
0.001
(0.007)
-0.013***
(0.005)

𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 × 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1
Constants
Controls
Fixed-effects
R2
Observations
Number of hospitals

0.413***
(0.031)
Yes
Yes
0.245
2,892
603

0.410***
(0.031)
Yes
Yes
0.245
2,892
603

0.446***
(0.030)
Yes
Yes
0.255
2,892
603

0.445***
(0.030)
Yes
Yes
0.255
2,892
603

0.425***
(0.029)
Yes
Yes
0.301
2,892
603

(6)
-0.004
(0.006)
-0.029***
(0.007)
0.007
(0.009)
-0.001
(0.004)
-0.020***
(0.007)
-0.003
(0.006)

-0.010
(0.006)
0.420***
(0.029)
Yes
Yes
0.299
2,892
603

Note: Robust standard errors are in parentheses. ***p<0.01, **p<0.05, *p<0.1. The results of the control variables are
not shown for expositional brevity.
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The coefficients for 𝐻𝐼𝑇𝑖,𝑡−1 are negative and
significant in all subsamples. The coefficients for
𝐻𝐼𝑇𝑟−𝑖,𝑡−1 are also negative and significant for both EDI
and CDSS in all subsamples (-0.093, -0.061, and -0.040
for EDI and -0.099, -0.066, and -0.044 for CDSS, for
Panels A, B, and C, respectively). To compare the
spillover effects across subsamples, we further estimate
our models with the standardized variables. The
standardized coefficients of 𝐻𝐼𝑇𝑟−𝑖,𝑡−1 for Panels A, B,
and C are -0.605, -0.400, and -0.264 for EDI and -0.808,
-0.541, and -0.368 for CDSS, respectively. These results
consistently indicate the spillover effects of HIT
adoption are negatively proportional to HRRs’ HHIs.
We test the equality of the coefficients across panels and
find that the difference between the standardized
coefficients from Panel A and Panel B, and Panel B and
Panel C is statistically significant for both EDI and
CDSS (the t-values are -5.048 and -3.297 for EDI, and 4.785 and -3.847 for CDSS, respectively). The results
imply that spillover effects are greatest for HRRs with a
low-concentrated market, followed by HRRs with a
moderately and a highly concentrated market. Further,
the coefficient estimate of the interaction term is found
significant only for CDSS and in low-concentrated
markets (-0.018 at p-value < 0.01 in Model (4) at Table
3).
The results illustrate that spillover effects depend on
HRRs’ market structures. Specifically, the effects are
prevalent when the healthcare market is very
competitive, such that there are many hospital choices
for referrals or collaborations. These effects, however,
diminish when a few hospitals are dominating in the
referral region.

4.2. The role of EDI in generating the spillover
effects of CDSS
EDI systems have been adopted to support effective
communication among hospitals. EDI allows hospitals
to exchange electronic clinical documentation such as
patient demographics, physician notes, nursing notes,
medication lists, and problem lists in a fast and errorless
manner. The diagnosis and treatment history, and
medication records supported by CDSS at the initial
hospital can be safely transmitted to the referred hospital
through the system.
To estimate the technology dependency of CDSS on
EDI in generating spillover effects, we incorporate a
three-way interaction term into our main models (Eq. 3
and Eq. 4):

𝑟ℎ𝑓𝑖,𝑡 = 𝛽0 + 𝛽1 𝐸𝐷𝐼𝑖,𝑡−1 + 𝛽2 𝐸𝐷𝐼𝑟−𝑖,𝑡−1 + 𝛽3 𝐸𝐷𝐼𝑖,𝑡−1 ×
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 + 𝛽4 𝐶𝐷𝑆𝑆𝑖,𝑡−1 + 𝛽5 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 +
𝛽6 𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 + 𝛽7 𝐸𝐷𝐼𝑖,𝑡−1 ×
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑖,𝑡−1 + 𝛾𝑋𝑖,𝑡 + 𝜇𝑖 + 𝜀𝑖,𝑡
(Eq.3)
𝑟ℎ𝑓𝑖,𝑡 = 𝛽0 + 𝛽1 𝐸𝐷𝐼𝑖,𝑡−1 + 𝛽2 𝐸𝐷𝐼𝑟−𝑖,𝑡−1 + 𝛽3 𝐸𝐷𝐼𝑖,𝑡−1 ×
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 + 𝛽4 𝐶𝐷𝑆𝑆𝑖,𝑡−1 + 𝛽5 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 +
𝛽6 𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 + 𝛽7 𝐸𝐷𝐼𝑖,𝑡−1 ×
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 + 𝛾𝑋𝑖,𝑡 + 𝜇𝑖 + 𝜀𝑖,𝑡
(Eq. 4)

Models (5) and (6) of Table 1 contain the analysis
results. The negative and significant coefficient of
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑖,𝑡−1 demonstrates that
the main effects of CDSS adoption are greater when
both a focal hospital and its neighbors have
implemented EDI. The negative and significant
coefficient of 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1
demonstrates that the spillover effect of CDSS adoption
is significant among hospitals in an HRR. These
findings further imply that the effects of hospitals’
CDSS and EDI adoptions are interdependent for
delivering high-quality healthcare service.

4.3. Network externality: HRR-level analysis
Considering possible spillover effects, the overall
HIT adoption at the HRR level could contribute to the
healthcare quality of the region. We conduct an HRRlevel analysis to examine how an HRR’s average
adoption rates of EDI and CDSS affect its average
readmission rate. The model specifications are the same
as our main models, except that all of the variables are
HRR-level.
Table 6. HRR-level estimation results
Variables
𝐸𝐷𝐼𝑟,𝑡−1

(1)
-0.034***
(0.005)

𝐶𝐷𝑆𝑆𝑟,𝑡−1

(2)

-0.032***
(0.004)

(3)
-0.026***
(0.004)
-0.027***
(0.004)

0.767***
(0.067)
Yes
Yes
0.463
1,150

0.734***
(0.066)
Yes
Yes
0.487
1,150

𝐸𝐷𝐼𝑟,𝑡−1
× 𝐶𝐷𝑆𝑆𝑟,𝑡−1
Constants

0.748***
(0.070)
Yes
Yes
0.449
1,150

(4)
-0.017
(0.013)
-0.012
(0.019)
-0.016
(0.020)
0.724***
(0.066)
Yes
Yes
0.487
1,150

Controls
Fixed-effects
R2
Observations
Number of
232
232
232
232
HRRs
Note: EDIr,t-1 (CDSSr,t-1) is the average adoption rate of EDI
(CDSS) of the HRR r at t-1. The dependent variable is the
average readmission rate of heart failure in the HRR. The
results of the control variables are not shown for expositional
brevity.
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Table 6 contains the results. The average adoption
rates of EDI (-0.026 at p-value < 0.01) and CDSS (0.027 at p-value < 0.01) in an HRR are associated with
a decrease in the average readmission rate of the HRR,
which illustrates the negative effects. However, their
interaction does not have any effect at the HRR level.

relatively low-level actual usage cannot fully utilize
adopted CDSS for a better quality of care. Further, the
interaction terms of 𝐻𝐼𝑇𝑖,𝑡−1 and 𝐻𝐼𝑇𝑟−𝑖,𝑡−1 have
insignificant coefficients for both EDI and CDSS
(Models (6) and (8)), implying that meaningful HIT
usage drives the spillover effects in an HRR.

4.4. Meaningful use

5. Conclusion

In terms of HIT adoption, an assimilation gap
between simple HIT implementation and actual usage
could exist in a hospital [12], and gap ranges are
possibly diverse across hospitals. Such gaps normally
result from a lack of knowledge in leveraging various
types of HIT and misalignment between HIT and
internal clinical workflows. Thus, we further integrate a
hospital’s actual usage, which is measured as a
hospital’s meaningful-use attestation, into our models.
This analysis can identify how the effect of HIT
adoption varies with a hospital’s actual usage. Actual
usage was measured by whether a hospital attested to
the meaningful-use Stage 2, which was initiated in 2014
and expanded the meaningful-use Stage 1 criteria (i.e.,
improving data capture and sharing) to advanced care
processes with decision support. The purposes of the
meaningful-use Stage 2 beyond Stage 1 are well aligned
with the adoption of CDSS and EDI. While Stage 1 does
not pay much attention to data exchange and the use of
CDSS, Stage 2 requires all medical documents to be sent
electronically to other hospitals for at least 50 percent of
referral cases and concerns the meaningful use of CDSS
functionalities.
Thus, we further test whether meaningful use, which
is measured by the receipt of the Stage 2 certificate,
makes any difference on the spillover effects of HIT
adoption. We apply our panel models, Eq. 1 and Eq. 2,
to hospitals that are certified as Stage 2 and hospitals
that are not certified, separately. There are 1,525
hospitals in Stage 2 and 440 hospitals in Stage 1 or
below in 2015.
Table 7 shows the estimation results. With respect to
Stage 2 hospitals, the estimates for 𝐻𝐼𝑇𝑖,𝑡−1 and
𝐻𝐼𝑇𝑟−𝑖,𝑡−1 are negative and significant in Models (1)
and (3), and the estimates for their interaction terms are
also negative and significant for both EDI and CDSS in
Models (2) and (4).
However, in Stage 1 hospitals, the effects of HIT
adoption (especially, CDSS) become insignificant in
Model (6) ~ (8), suggesting that hospitals having

This study investigates the effects of CDSS and EDI
on the hospital readmission rates for heart failure
patients. Using the large-scale hospital panel datasets
from multiple sources, we find evidence that a hospital’s
HIT adoption is associated with a subsequent reduction
in its readmission rate. We also reveal the spillover
effects of HIT adoption within an HRR. These spillover
effects become stronger for an HRR with less
concentrated healthcare markets – competitive
healthcare markets. Furthermore, our results indicate
that a focal hospital’s EDI adoption along with its
neighboring hospitals is critical in fostering the spillover
effects of CDSS adoption in the HRR.
Our results highlight the importance of governmentdriven HIT investments in the U.S. The spillover effects
become greater for hospitals that have adopted HIT,
along with a higher HIT adoption level within the HRR.
The negative impact of HIT adoption on a hospital’s
readmission rate can be greater with the adoption of the
other hospitals in the HRR.
Such spillover effects vary with the market
concentrations of regional healthcare markets. The
spillover effects of both EDI and CDSS are strongest for
HRRs with an unconcentrated healthcare market,
followed by HRRs with a moderately concentrated
healthcare market. The spillover effects are weakest for
HRRs with a highly concentrated healthcare market.
This finding suggests that policies for effective HIT
adoption should consider various regional market
structures. Therefore, government interventions aiming
at maximizing the spillover effects of HIT adoption
need to be tailored, based on types of healthcare market
structures.
The spillover effect of CDSS adoption becomes
greater when a focal hospital adopts EDI and the
average EDI adoption rate of neighboring hospitals in
its HRR is higher. EDI adoption moderates the spillover
effects of CDSS adoption. This indicates the technology
interdependence among HITs in enhancing healthcare
quality.
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Table 7. Estimation results of hospitals by meaningful use
Variables
𝐸𝐷𝐼𝑖,𝑡−1
𝐸𝐷𝐼𝑟−𝑖,𝑡−1

(1)
-0.007***
(0.002)
-0.058***
(0.003)

𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1

Hospitals in Stage 2
(2)
(3)

𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1

-0.006***
(0.002)
-0.066***
(0.003)

0.006
(0.004)
-0.053***
(0.005)
-0.019***
(0.006)

0.431***
(0.023)
Yes
Yes
0.274
7,464
1,525

0.426***
(0.023)
Yes
Yes
0.276
7,464
1,525

𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1

Controls
Fixed-effects
R2
Observations
Number of hospitals

0.429***
(0.025)
Yes
Yes
0.235
7,464
1,525

0.418***
(0.025)
Yes
Yes
0.236
7,464
1,525

(5)

Hospitals in Stage 1 or Below
(6)
(7)
(8)

-0.004*
(0.002)
-0.059***
(0.004)

0.006
(0.006)
-0.043***
(0.006)
-0.016**
(0.007)

𝐶𝐷𝑆𝑆𝑖,𝑡−1

Constants

(4)

0.331***
(0.042)
Yes
Yes
0.290
2,077
440

0.010
(0.010)
-0.044***
(0.012)
-0.016
(0.012)

0.317***
(0.042)
Yes
Yes
0.291
2,077
440

-0.004
(0.003)
-0.060***
(0.007)

-0.010
(0.007)
-0.066***
(0.008)
0.011
(0.011)

0.346***
(0.042)
Yes
Yes
0.283
2,077
440

0.348***
(0.042)
Yes
Yes
0.284
2,077
440

Note: Robust standard errors are in parentheses. ***p<0.01, **p<0.05, *p<0.1. The results of the control variables are
not shown for expositional brevity
Our study contributes to the growing body of
literature on the impacts of HITs. While most prior
empirical studies focus on the hospital or physicianlevel effects of HIT adoption based on a small sample,
we use nationwide large panels to examine not only the
hospital-level effects of the adoption but also possible
spillover effects at an HRR level. A few recent studies
have paid attention to the spillover effects of HIT
adoptions; however, their focus is on the cost side [3, 5].
To the best of our knowledge, this study is one of the
first studies to provide empirical evidence of the
spillover effects of HIT adoption on healthcare quality
considering market concentrations and actual usage
beyond simple HIT implementation. The subsample
analysis across various market concentrations provides
the market conditions where spillover effects can prevail.
The analysis on the three-way interaction of EDI
adoption, the EDI adoption rate in the HRR, and CDSS
adoption highlights the importance of infrastructure for
effective communication among hospitals in terms of
fostering the spillover effects of standalone technology.
We further found that the spillover effects of HIT
adoption increase along with higher actual HIT usage.
While we focus on the effects of two types of
HITs—CDSS and EDI, the effects of other HITs can be
explored as well in the next step. If an analysis of other
technologies shows different results, such that no
spillover effect is found, it would be interesting to
investigate which technological characteristics of HITs
drive such differential results. We can also replicate the
analysis for other major causes of hospital readmission,

such as pneumonia or acute myocardial infarction, in
our future research.
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